Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

European approval sought for new Rebif indications

Aug. 23, 1996

U.S. patent will issue covering GLIOMAB-H

Aug. 16, 1996

BEC2, ImClone Systems' therapeutic vaccine protected under U.S. patent

Aug. 9, 1996

Larifane shown effective in cervical dysplasia/cancer patients

July 26, 1996

Humanized CD38 antibodies for cancer/autoimmune disease treatment

July 26, 1996

Multikine enters Canadian phase I/II trial

July 12, 1996

Antitumor vaccines described by University of Pennsylvania

July 5, 1996

Human Genome Sciences reports discovery of TNF-gamma

July 5, 1996

Virulizin undergoes phase I/II in pancreatic cancer

June 28, 1996

Multikine covered under Japanese patent

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...